Skip to main content
TOPRA
Toggle search
Keyword search
Toggle navigation
Keyword search
BECOME A MEMBER
CONTACT US
Sign in
About
Toggle
Our mission and values
Our history
Governance
Who's who
Contact us
Find us
Partnerships and Affiliations
TOPRA Strategic Plan 2020–2025
What is Regulatory Affairs?
Membership & Communities
Toggle
Member updates
Membership
Employer Partner
Communities
Volunteering
Become a Fellow
Diversity & Inclusion
Board elections
Professional Development
Toggle
Career progression
All courses & events
Training
Conferences & networking
Qualifications
Apprenticeship
Professional registration
CPD and lifelong learning
Innovation Summit
TOPRA Summit
Regulatory Careers Live
TOPRA Jobs
Degree accreditation
Symposium
Publications & Resources
Toggle
News & insights
Regulatory Rapporteur
Members-only newsletters
TOPRA Engage+ App
TOPRA Connect newsletter
Medical device resources
Reg Intelligence Knowledge Hub
Sustainability
Wall Planner
Glossary of RA terms
Commercial Services
Toggle
Advertising opportunities
Exhibition opportunities
Hire our meeting rooms
Sponsorship opportunities
Services directory
TOPRA Jobs
Awards
About TOPRA
Professional development
My TOPRA
TOPRA shop
Membership & communities
TOPRA services
The Role of Real-World Evidence in Health Technology Develop
Registration is now open for TOPRA in Scotland's final meeting of 2025 to be held at the ACD Centre. Join us, and our expert speakers, as we discuss the role of real-world (RWE) evidence in health technology development. RWE continues to gain prominence as a tool in health technology development with developers and regulators both looking to leverage the insights it can offer to support alternative pathways to market - whether it is through external control arms or post-launch evidence generation - there's a lot to be aware of. Despite this, the regulatory considerations around RWE are often misunderstood. Join us and our expert speakers as we look to remove some of these misunderstandings with our expert speakers.
Date:
12/11/2025
Time:
14:00 - 17:00
Fit for Purpose? The Regulatory Evolution of Real-World Evidence in Medicines Development
This session will explore how regulators across Europe and the globe are shaping expectations for RWE generated from non-interventional (drug) studies (NIS). It will highlight recent guidance updates, trends in regulatory decision-making and practical considerations for designing and conducting RWE studies that are "fit for purpose" in regulatory submissions.
Speaker
:
Stuart McCully is a regulatory and operational expert in real-world research (RWR), with over two decades of experience supporting the design and delivery of non-interventional studies (NIS) across the globe. He is the founder of Phoenix-RWR and co-founder of RWR-Regs, a regulatory intelligence platform dedicated to NIS compliance. Stuart contributed to the development of the DIA TMF reference model for NIS and is a recognized thought leader in the intersection of regulation, methodology, and operational practice in RWE.
When
12/11/2025 14:00 - 17:00
Where
The Sir Arthur Conan Doyle Centre 25 Palmerston Place Edinburgh EH12 5AP UNITED KINGDOM
Registration begins 30/05/2025 14:00 (GMT Daylight Time)
My registration status:
Not registered
Your company name
Your VAT country
Your VAT number
NOTE
Important instructions before booking -
If your company name or VAT number does not appear here or you would like to be invoiced using a different VAT number, please email
finance@topra.org
Register now
Username
Required
Password
Required
Keep me signed in
Forgot username?
|
Forgot password?
Create an account
Share this page
Share on Facebook
Share on Twitter
Share on LinkedIn
Email
More options
Bookmarks
Google+
MySpace
Reddit
StumbleUpon
Tumblr
Yammer
Previous
Next
Previous
Next
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##